Trial Profile
Motion Serifos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Feb 2024
Price :
$35
*
At a glance
- Drugs Tradipitant (Primary)
- Indications Motion sickness
- Focus Registrational; Therapeutic Use
- Sponsors Vanda Pharmaceuticals
- 07 Feb 2024 According to a Vanda Pharmaceuticals media release, over 50% enrolled in this study.
- 08 Nov 2023 According to a Vanda Pharmaceuticals media release, over 20% patients are enrolled in this study.
- 20 Jun 2023 New trial record